• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A search and optimization of the novel cancer molecules target drugs with PI3K/HDAC dual inhibition

Research Project

Project/Area Number 24300339
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field Clinical oncology
Research InstitutionTohoku University

Principal Investigator

ISHIOKA Chikashi  東北大学, 加齢医学研究所, 教授 (60241577)

Co-Investigator(Kenkyū-buntansha) KATO Tadashi  東北薬科大学, 薬学部, 教授 (50382669)
SAIJO Ken  東北大学, 病院, 助教 (70636729)
Research Collaborator LI Jin  
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥19,370,000 (Direct Cost: ¥14,900,000、Indirect Cost: ¥4,470,000)
Fiscal Year 2014: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2013: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2012: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000)
Keywords分子標的治療薬 / PI3K阻害薬 / HDAC阻害薬 / 創薬 / がん / PI3K / HDAC
Outline of Final Research Achievements

Novel FK228 analogs as PI3K/HDAC dual inhibitors were synthesized, and, by docking simulation of a new analog and PI3K catalytic subunit p100α, and an evaluation of the PI3K inhibitory activity, we synthesized new analog FK-A11 which was stronger PI3K inhibitory activity than FK228 and its analog FK-A5. We found that the novel FK228 analogs with the strong PI3K inhibitory activity had inhibitory activities on both the apoptotic induction and intracellular signal transduction and strongly suggested that the PI3K inhibitory activity correlated with antitumor effect of the compounds. We also found that the novel FK228 analog was effective against prostate cancer and colorectal cancer, particularly effective in colorectal cancer cells with the KRAS gene mutation refractory to anti-EGFR antibody, a molecular target drug. Also, we found that FK-A11 was a pan-PI3K inhibitor and an ATP-competitive inhibitor.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Annual Research Report
  • 2012 Annual Research Report
  • Research Products

    (10 results)

All 2015 2014 2013 2012

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Acknowledgement Compliant: 2 results,  Open Access: 1 results) Presentation (5 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 2 results)

  • [Journal Article] Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.2015

    • Author(s)
      2.Saijo, K.,Imamura, J.,Narita, K.,Oda, A.,Shimodaira, H.,Katoh, T.,Ishioka, C.
    • Journal Title

      Cancer Sci

      Volume: 106 Issue: 2 Pages: 208-215

    • DOI

      10.1111/cas.12585

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Predicting the structures of complexes between phosphoinositide 3-kinase (PI3K) and romidepsin-related compounds for the drug design of PI3K/histone deacetylase dual inhibitors using computational docking and the ligand-based drug design approach.2014

    • Author(s)
      Oda, A.,Saijo, K.,Ishioka, C.,Narita, K.,Katoh, T.,Watanabe, Y.,Fukuyoshi, S.,Takahashi, O.
    • Journal Title

      J Mol Graph Model

      Volume: 54 Pages: 46-53

    • DOI

      10.1016/j.jmgm.2014.08.007

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Romidepsin (FK228) and its analogs directly inhibit PI3K activity and potently induce apoptosis as HDAC/PI3K dual inhibitors2012

    • Author(s)
      Ken Saijo, Tadashi Katoh, Hideki Shimodaira, Akifumi Oda, Ohgi Takahashi, Chikashi Ishioka
    • Journal Title

      Cancer Science

      Volume: 103 Issue: 11 Pages: 1994-2001

    • DOI

      10.1111/cas.12002

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Presentation] 新規HDAC/PI3K 2重阻害剤としてのデプシペプチド類縁体の抗腫瘍活性の検討2014

    • Author(s)
      西條憲,李仁,成田紘一,加藤正,下平秀樹,石岡千加史
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-27
    • Related Report
      2014 Annual Research Report
  • [Presentation] In vitroおよびin vivoにおけるPI3K/HDAC 2重阻害剤としてのFK228類縁体の抗腫瘍効果の評価2014

    • Author(s)
      李仁,西條憲,下平秀樹,成田紘一,加藤正,石岡千加史
    • Organizer
      第18回日本がん分子標的治療学会学術集会
    • Place of Presentation
      仙台
    • Year and Date
      2014-06-26
    • Related Report
      2014 Annual Research Report
  • [Presentation] Romidepsin(FK228) and its analogs exhibit potent cytotoxicity through HDAC/PI3K dual inhibition in colorectal cancer cell lines.2013

    • Author(s)
      Saijo K, et al.
    • Organizer
      AACR/JCA Joint Conference
    • Place of Presentation
      Maui, Hawai, USA
    • Year and Date
      2013-02-24
    • Related Report
      2012 Annual Research Report
  • [Presentation] 457. HDAC/PI3K dual inhibitorとしてのRomidepsin(FK228)新規類縁体の開発と最適化2013

    • Author(s)
      李仁, 西條憲, 下平秀樹, 成田紘一, 加藤正, 石岡千加史
    • Organizer
      第17回日本がん分子標的治療学会
    • Place of Presentation
      京都
    • Related Report
      2013 Annual Research Report
  • [Presentation] 新規HDAC/PI3K 2重阻害剤としてのロミデプシン類縁体の同定2012

    • Author(s)
      西條憲, ほか
    • Organizer
      第16回がん分子標的治療学会学術集会
    • Place of Presentation
      北九州市
    • Year and Date
      2012-06-27
    • Related Report
      2012 Annual Research Report
  • [Patent(Industrial Property Rights)] Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition2014

    • Inventor(s)
      西條憲、石岡千加史、加藤正
    • Industrial Property Rights Holder
      東北大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2014-05-27
    • Related Report
      2014 Annual Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] 新規ホスファチジルイノシトール3キナーゼ阻害剤及び医薬組成物2012

    • Inventor(s)
      西條憲, 石岡千加史, 加藤正
    • Industrial Property Rights Holder
      東北大学
    • Filing Date
      2012-09-25
    • Related Report
      2012 Annual Research Report
    • Overseas

URL: 

Published: 2012-04-24   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi